Dostinex
Dostinex
- In our pharmacy, you can buy dostinex without a prescription, with delivery across Canada in 5–14 days and discreet, secure packaging.
- Dostinex (cabergoline) is used to treat hyperprolactinemia, prolactin-secreting pituitary adenomas and related menstrual/fertility disorders; it is a dopamine D2 receptor agonist that inhibits prolactin secretion from the pituitary.
- The usual dose is 0.5 mg per week (given as a single dose or divided); dose may be increased by 0.5 mg/week as needed, typical maintenance up to 1 mg twice weekly and a common maximum of about 2 mg/week (higher doses used rarely under specialist supervision).
- Form of administration: oral tablet (commonly 0.5 mg tablets, supplied in bottles or blister packs).
- Onset time: serum prolactin levels typically begin to fall within 2–3 days, while symptomatic improvement may take several days to a few weeks.
- Duration of action: long-acting — cabergoline has a prolonged effect lasting several days to about a week after a dose; treatment is often continued until prolactin is normal for at least 6 months or as directed by a specialist.
- Alcohol warning: avoid or minimise alcohol while taking dostinex as alcohol can worsen dizziness, fainting (orthostatic hypotension) and sedation.
- The most common side effec is nausea (other common adverse effects include headache, dizziness, constipation, fatigue and orthostatic hypotension; rare psychiatric effects such as hallucinations or impulse-control disorders have been reported).
- Would you like to try dostinex without a prescription?
Availability & Price Landscape
Basic Dostinex Information
- INN (International Nonproprietary Name): Cabergoline
- Brand Names Available In Canada (English): Dostinex; Cabaser; generics labelled as "cabergoline" or manufacturer-specific names such as Apo‑Cabergoline.
- ATC Code: G02CB03
- Forms & Dosages: Tablet (oral) 0.5 mg commonly in bottles or blister packs (usually 2, 8, or 30 tablets). 0.25 mg and 1 mg tablets appear in some generic markets but are rare.
- Manufacturers In Canada (English): Pfizer is the originator (Dostinex). Numerous generic manufacturers supply cabergoline globally; local pharmacy or national drug registry can confirm Canadian suppliers.
- Registration Status In Canada (English): Not specified in the provided data; check Health Canada Drug Product Database for current listings and DINs.
- OTC / Rx Classification: Prescription Only Medicine (Rx) in all markets.
Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)
Dostinex (cabergoline) is prescription-only across Canada.
Major chains commonly dispense generic cabergoline rather than the originator Pfizer Dostinex in many locations.
Packaging varies by supplier and may be supplied in bottles or blister packs.
Ask the local pharmacist for the exact Drug Identification Number (DIN) and manufacturer when collecting the medicine.
- Shoppers Drug Mart: Typically dispenses generics labelled as cabergoline; availability varies by store.
- Rexall: Often stocks generic cabergoline; call ahead for pack sizes.
- London Drugs: Stocks generics and serves BC/Alberta customers; check specific store inventory.
- Jean Coutu (Quebec): Serves Quebec market with supplier differences; verify packaging and DIN locally.
Online Pharmacy Trends In Canada (Including Provincial Restrictions)
Licensed Canadian online pharmacies sell cabergoline with e-prescription verification and pharmacist counselling.
Provincial colleges require prescription validation and sometimes restrict dispensing to pharmacists licensed in that province.
Cross-border ordering from U.S. or other foreign vendors happens but carries regulatory and customs risks and may affect reimbursement eligibility.
- Verification Steps
- Patient submits valid prescription or e-prescription.
- Pharmacist verifies prescription against provincial college requirements.
- Pharmacy confirms product DIN, manufacturer and dispenses with counselling and shipping instructions.
Price Ranges By Package Size (With Provincial Differences)
Prices vary by brand versus generic, pack size and provincial listing or private insurance coverage.
Branded Dostinex generally costs more than generics in the same strength.
| Province | Typical Pack Sizes | Price Band (CAD) |
|---|---|---|
| Ontario | 2, 8, 30 tablets (0.5 mg) | $30–$150 depending on brand and pack size |
| British Columbia | 2, 8, 30 tablets (0.5 mg) | $25–$140 depending on brand and pack size |
| Quebec | 2, 8, 30 tablets (0.5 mg) | $28–$145 depending on brand and pack size |
| Alberta | 2, 8, 30 tablets (0.5 mg) | $27–$150 depending on brand and pack size |
| Atlantic Provinces | 2, 8, 30 tablets (0.5 mg) | $30–$155 depending on brand and pack size |
Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may cover cabergoline when clinical criteria are met.
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)
Canadian patients discuss cabergoline on Reddit communities and condition-specific forums such as HealthBoards and AskDocs.
Common discussion points include access to prescriptions, side-effect experiences and switching between brand Dostinex and generics.
Users often share dosing schedules they received, but most emphasize confirming regimens with the prescriber.
Many report helpful pharmacy counselling at chain pharmacies when starting or switching cabergoline tablets.
Reported Benefits And Challenges From Canadian Patients
Benefits commonly reported include fast reduction in prolactin-related symptoms and the convenience of weekly dosing schedules.
Challenges often include nausea, dizziness and variability when switching manufacturers.
- "My periods returned after a few weeks on cabergoline, and the weekly dosing was easy to remember."
- "I felt dizzy the first two doses and my pharmacist suggested taking it with food and sitting up slowly."
- "Switched from Dostinex to a generic and noticed a slight difference in side effects; pharmacist confirmed DIN and counselling helped."
- "Waiting on prior authorisation with the provincial plan caused a couple weeks' delay in starting therapy."
Overall sentiment leans positive when patients receive timely monitoring and clear pharmacist advice.
Product Overview & Brand Variants
INN And Brand Names Used In Canada
The International Nonproprietary Name is cabergoline.
Dostinex is the originator brand from Pfizer and is used internationally.
Generics commonly appear under "cabergoline" or manufacturer labels such as Apo‑Cabergoline in various markets.
| INN | Common Brand/Label | Typical Strength |
|---|---|---|
| Cabergoline | Dostinex (Pfizer) | 0.5 mg |
| Cabergoline | Generics (Apo‑Cabergoline, local labels) | 0.5 mg (0.25 mg and 1 mg rare) |
Legal Classification Under Health Canada
Cabergoline is a prescription-only medication in Canada.
Products approved for sale must carry a Drug Identification Number (DIN) issued by Health Canada.
- DIN
- Identifies the specific product, strength and manufacturer for dispensing and reimbursement.
- Rx Status
- Valid prescription is required and pharmacists must verify indications and interactions per provincial practice standards.
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada DIN Context)
Cabergoline is primarily indicated for hyperprolactinemia and prolactin-secreting pituitary adenomas.
Standard initiation is around 0.5 mg per week with titration based on prolactin response and tolerability.
| Indication | Typical Start Dose | Maintenance/Max |
|---|---|---|
| Hyperprolactinemia | 0.5 mg/week (single or divided) | Maintenance varies; typical max 2 mg/week (rare cases up to 4.5 mg) |
| Prolactinoma | As above | As above |
Prescribers reference DIN-labelled indications when applying for public drug plan coverage.
Off-Label Patterns In Canadian Healthcare
Off-label use is uncommon but may occur under specialist supervision.
- Adjunctive reproductive endocrinology uses in selected cases, documented by specialists.
- Higher doses for Parkinsonian syndromes are used internationally but are uncommon in Canada.
- Off-label prescribing should be documented for safety monitoring and reimbursement purposes.
How It Works In The Body
Layman’s Explanation (Canadian Patient-Friendly Tone)
Cabergoline is a dopamine agonist that tells the pituitary gland to lower prolactin production.
Lower prolactin can stop unwanted milk production, restore menstrual cycles and improve fertility related to hyperprolactinemia.
The medicine is long-acting, which is why weekly dosing is often possible and convenient for many patients.
Clinical Detail From Health Canada Resources
Cabergoline is an ergot-derived D2 dopamine receptor agonist with a long half-life enabling infrequent dosing.
Clinical guidance supports starting at 0.5 mg/week and monitoring prolactin levels to guide titration.
Monitor cardiac status when using higher or long-term doses because of possible valvulopathy risk noted with ergot-derived agents.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
Typical adult regimen for hyperprolactinemia begins at 0.5 mg per week, given as a single weekly dose or split into two smaller doses.
Titrate by roughly 0.5 mg/week based on prolactin measurements and symptom control.
Usual maintenance doses are individualized; many patients remain on low weekly doses once prolactin normalizes.
| Indication | Start | Usual Maintenance | Notes |
|---|---|---|---|
| Hyperprolactinemia | 0.5 mg/week | 0.5–2 mg/week | Monitor prolactin; adjust every 4–6 weeks as needed |
| Prolactinoma | 0.5 mg/week | Up to 2 mg/week typical; specialist may use higher doses with monitoring | Consider imaging and endocrine follow-up |
Adjustments By Patient Type (With Canadian Clinical Notes)
Children: use is not established and is not routinely recommended.
Elderly: no formal dose reduction, but monitor closely for adverse reactions in patients over 65.
Hepatic impairment: start with lower doses and increase cautiously; monitor liver function.
Renal impairment: no routine adjustment, but clinical monitoring advised for severe dysfunction.
- Counselling point: review pregnancy plans before starting; lactation is generally contraindicated for suppression purposes.
- Counselling point: provide a written dosing schedule and follow-up appointment reminders.
Contraindications & Side Effects
Common (Health Canada-Approved List)
Absolute contraindications include uncontrolled hypertension and hypersensitivity to cabergoline or ergot derivatives.
A history of cardiac valvulopathies is a contraindication due to potential fibrotic valve risk with ergot derivatives.
Common side effects include nausea, constipation, headache, dizziness, fatigue and orthostatic hypotension.
- Pharmacy counselling checklist: advise on standing slowly, avoiding driving until effects settle and taking with food if nausea occurs.
Rare But Serious (With Canadian Pharmacovigilance Data)
Rare serious reactions include psychiatric effects such as hallucinations and impulse control disorders.
Valvular heart disease is a potential concern with long-term or high-dose use of ergot-derived dopamine agonists.
Report serious adverse events to Health Canada’s Canada Vigilance Program and keep clear documentation in the patient record.
Comparable Medicines In Canada
Alternatives Table (With DIN References)
| Medicine | Dosing Frequency | Common Side Effects | DIN (Verify Locally) |
|---|---|---|---|
| Cabergoline (Dostinex / generics) | Weekly (often) | Nausea, dizziness, orthostatic hypotension | Check local pharmacy for specific DIN |
| Bromocriptine (Parlodel / generics) | Daily | More GI side effects, hypotension | Check local pharmacy for specific DIN |
| Quinagolide (Norprolac) | Daily (where available) | Less common in Canada; compare tolerability | Check local pharmacy for specific DIN |
Pros And Cons List
- Cabergoline Pros: less frequent dosing, generally better tolerability, effective for tumour shrinkage.
- Cabergoline Cons: ergot-derived with valvulopathy concerns at high cumulative doses, potential cost higher than older generics.
- Bromocriptine Pros: longer experience, lower-cost generics widely available.
- Bromocriptine Cons: daily dosing and more gastrointestinal side effects for some patients.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
Recent studies have focused on long-term cardiac safety at higher cumulative doses and real-world fertility outcomes after cabergoline therapy.
Head-to-head tolerability comparisons versus bromocriptine remain a focus, particularly regarding quality-of-life outcomes.
Canadian tertiary centres contribute registry data on prolactinoma outcomes and follow-up strategies that prioritise dose minimisation once remission is achieved.
Key takeaways: clinicians are cautious with high-dose or long-term therapy and often recommend baseline cardiac assessment when doses exceed usual maintenance ranges.
Common Patient Questions In Canada
Do I need a special prescription?
Yes, cabergoline is prescription-only and pharmacists will verify the prescription and clinical history before dispensing.
Will provincial drug plans pay?
Coverage varies by province and requires meeting specific clinical criteria; prescribers often reference the DIN-labelled indication when applying for coverage.
Can I get it online?
Licensed Canadian online pharmacies dispense cabergoline with a valid prescription and pharmacist verification; cross-border options carry risk and may not be reimbursable.
What if I miss a dose?
Take the missed dose as soon as remembered unless it is close to the next scheduled dose; do not double doses.
Is it safe in pregnancy or breastfeeding?
Use in pregnancy only if the prescriber judges benefits outweigh risks; lactation suppression for convenience is not recommended due to serious risks.
Regulatory Status
Health Canada Approval Process
Cabergoline products must be approved by Health Canada and listed in the Drug Product Database with a DIN.
Approval assesses quality, safety and efficacy and the product monograph provides prescribing and monitoring guidance.
DIN Number Relevance
The DIN identifies the exact product, strength and manufacturer and is required for reimbursement claims with provincial drug programs.
When discussing brand versus generic substitution, compare DINs to confirm product identity and substitution policies under provincial pharmacy acts.
Visual Recommendations
Infographic Ideas For Canadian Context
Design a "How Cabergoline Works" flowchart showing pituitary → prolactin → symptom improvement.
Create a "Weekly Dosing Calendar" graphic that patients can download and stick on the fridge.
Provide a "When To Call Your Pharmacist" icon set for dizziness, severe nausea, chest symptoms and mood changes.
Include a simple provincial coverage checklist map so patients know which documents may be required for prior authorisation.
Product Imagery & Packaging Display
Use clear photos showing the tablet strength (0.5 mg) and the DIN on packaging when permission is available.
Display common pack sizes such as 2, 8 and 30 tablets and list the manufacturer beside each image for transparency.
Ensure images comply with Health Canada rules for prescription product advertising and do not promote off-label use.
Buying & Storage Advice
In-Store Vs. Online Canadian Purchase Tips
In-store purchase gives immediate pharmacist counselling and an opportunity to check blood pressure or orthostatic vitals before first dose.
Online licensed Canadian pharmacies require a valid e-prescription and will provide counselling by phone or secure message when dispensing.
In our online pharmacy, dostinex is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
- Verification checklist: confirm DIN, confirm manufacturer, request pharmacist counselling, check provincial coverage paperwork.
- Avoid unverified foreign sellers that do not provide DINs, product monographs or pharmacist contact information.
Proper Storage With Canadian Climate Considerations
Store cabergoline between 20–25°C (68–77°F) and protect from moisture and light.
Do not leave tablets in cars during winter or summer transit where temperature extremes occur.
Keep medication in the original packaging with any desiccant and dispose of expired tablets at a pharmacy take-back if available.
Do not freeze the product during transport or storage.
Guidelines For Proper Use
Canadian Doctor/Pharmacist Advice Style
Confirm a baseline prolactin level before starting and repeat after dose changes to guide titration.
Consider an echocardiogram if patients require prolonged high-dose therapy, and document the rationale and consent for off-label or high-dose regimens.
Start low, advise on orthostatic precautions, and provide written instructions for missed doses and when to seek care.
Patient Follow-Up And Monitoring Checklist
Check prolactin 4–6 weeks after starting or after each titration step.
Review blood pressure and orthostatic vitals at baseline and during early follow-up visits.
Screen for psychiatric symptoms at each visit and instruct patients to report new mood or behavioural changes promptly.
For prolonged high-dose therapy, discuss periodic cardiac assessment based on cumulative dose and specialist advice.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
| Victoria | British Columbia | 5-7 days |
| Charlottetown | Prince Edward Island | 5-9 days |
Quick Reference And Closing Notes
Cabergoline (INN: cabergoline) is an effective, long-acting dopamine agonist commonly supplied as 0.5 mg tablets such as Dostinex or generic cabergoline tablets.
It is prescription-only and requires monitoring of prolactin and clinical status, with attention to cardiac and psychiatric risks for long-term or high-dose use.
When picking up cabergoline tablets, confirm the DIN and manufacturer and request counselling about side effects and orthostatic precautions from your pharmacist.
For further details on a specific product or DIN, consult the Health Canada Drug Product Database or ask a licensed Canadian pharmacist for the product monograph and local pricing.